Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Immunose FLU (Eurocine Vaccines AB)
- Development stage
- Preclinical
- Lead developer
- Eurocine Vaccines
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intranasal
01
Overview
Immunose™ FLU is an investigational intranasal quadrivalent influenza vaccine candidate developed by Eurocine Vaccines AB. The vaccine combines quadrivalent influenza antigens, covering two influenza A and two influenza B strains, with Endocine™, a proprietary lipid-based adjuvant system composed of mono-olein and oleic acid. Designed for needle-free administration, the formulation is intended to induce both local mucosal immunity in the respiratory tract and systemic immune responses to prevent seasonal influenza. Clinical development has primarily focused on evaluating the safety, tolerability, and immunogenicity of the adjuvanted nasal spray, particularly for use in pediatric populations.
- Brand names
- Immunose FLU
- Other names
- quadrivalent influenza antigen + EndocineImmunose™ FLU
02
Targets
HA (Hemagglutinin)
Beyond the preview
Go deeper on Immunose FLU (Eurocine Vaccines AB).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Immunose FLU (Eurocine Vaccines AB).